Hyperglycaemia (the initiation of insulin therapy because of a blood glucose concentration > 120 mg/dL (6.7 mmol/L) in people without preexisting diabetes mellitus or increased doses of insulin in people with diabetes mellitus). This evidence concerns the gene INS and Hyperglycemia.